A mid-size pharma company wanted to launch their asset in the middle east following US approval, and they wanted to understand the key stakeholders in the region, the required HEOR evidence, and whether global or local data were needed during registration and reimbursement processes
To thoroughly understand the dynamics of individual country markets, while also considering broader regional dynamics, a combination of secondary and primary research was conducted to provide comprehensive and strategic analyses of the market access landscapes.
Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?
